We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Mark Hurwitz MD

Mark Hurwitz MD

Vice-Chair for Quality, Safety, and Performance Excellence; Director of Thermal Oncology, Department of Radiation Oncology, Thomas Jefferson University, Philadelphia, Pennsylvania

Mark Hurwitz, M.D. is Vice-Chair for Quality, Safety, and Performance Excellence and Director of Thermal Oncology for the Department of Radiation Oncology at Thomas Jefferson University.  He previously served as Director of Regional Program Development for the Department of Radiation Oncology at the Dana-Farber/Brigham and Women’s Cancer Center.   Since joining Thomas Jefferson in late 2012 he has been engaged in development of a comprehensive thermal oncology program.   Dr. Hurwitz is a widely recognized leader in the fields of thermal medicine and genitourinary oncology.  He is a Past-President of the Society for Thermal Medicine and currently serves on the editorial board of the International Journal of Hyperthermia.  He has been the recipient of NIH grant support for development of applications of hyperthermia and thermal ablation for treatment of prostate cancer and recently served as the principal investigator of an international multi-center phase III trial to assess the use of magnetic resonance guided focused ultrasound ablation for treatment of painful bone metastases.

Recent Contributions to PracticeUpdate:

  1. MRI-Guided Ultrasound for Painful Bony Metastasis